Association of glutathione S-transferase M1 polymorphisms and lung cancer risk in a Chinese population

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 188-190

  Liu, Dazhong ^a   Wang, Fei ^a   Wang, Qiushi ^a   Guo, Xiaotong ^a   Xu, Hao ^a   Wang, Wei ^a   Zhang, Linyou ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Gene polymorphism; Glutathione S transferase M1; Lung cancer

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE;

ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; GSTM1 GENE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SMOKING; CHINA; GENETIC POLYMORPHISM; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; RISK FACTOR;

CHINA; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84867212941     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.016     Document Type: Article

References (34)

1. Heuvers ME, Stricker BH, Aerts JG. Generalizing lung-cancer screening results. N Engl J Med 2012, 366, 192-3.
2. Zhu J, Sharma DB, Gray SW, Chen AB, Weeks JC, Schrag D. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA 2012, 307, 1593-601.
3. van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet 2011, 378, 1741-55.
4. Proctor RN. Tobacco and the global lung cancer epidemic. Nat Rev Cancer 2001, 1, 82-6.
5. Xie Y, Minna JD. Predicting the future for people with lung cancer. Nat Med 2008, 14, 812-3.
6. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 2001, 31, 139-48.
7. Litwack G, Ketterer B, Arias IM. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature 1971, 234, 466-7.
8. Thoudam RD, Yadav DS, Mishra AK, et al. Distribution of glutathione S-transferase T1 and M1 genes polymorphisms in North East Indians: a potential report. Genet Test Mol Biomarkers 2010, 14, 163-9.
9. Gra O, Mityaeva O, Berdichevets I, et al. Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians. Genet Test Mol Biomarkers 2010, 14, 329-42.
10. Shi X, Zhou S, Wang Z, Zhou Z. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 2008, 59, 155-63.
11. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol 2008, 167, 759-74.
12. Li W, Yue W, Zhang L, et al. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in nonsmall-cell lung cancer patients. Lung 2012, 190, 91-8.
13. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol 2012, 7, 954-62.
14. Timofeeva M, Kropp S, Sauter W, et al. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int J Cancer 2010, 127, 1547-61.
15. Jin Y, Xu H, Zhang C, et al. Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China. BMC Cancer 2010, 10, 422.
16. Gervasini G, San Jose C, Carrillo JA, Benitez J, Cabanillas A. GST polymorphisms interact with dietary factors to modulate lung cancer risk: study in a high-incidence area. Nutr Cancer 2010, 62, 750-8.
17. Cabral RE, Caldeira-de-Araujo A, Cabral-Neto JB, Costa Carvalho Mda G. Analysis of GSTM1 and GSTT1 polymorphisms in circulating plasma DNA of lung cancer patients. Mol Cell Biochem 2010, 338, 263-9.
18. Matakova T, Sivonova M, Halasova E, et al. Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population. Eur J Med Res 2009, 14(Suppl. 4), 275-9.
19. Kumar M, Agarwal SK, Goel SK. Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem 2009, 322, 73-9.
20. Lee KM, Kang D, Clapper ML, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 2008, 17, 1120-6.
21. Lee KM, Kang D, Lee SJ, et al. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep 2006, 16, 1035-9.
22. Ekim M, Caner V, Buyukpinarbasili N, Tepeli E, Elmas L, Bagci G. Determination of O(6)-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer. Genet Test Mol Biomarkers 2011, 15, 357-60.
23. Dai X, Liu Z, Ren J, Wu G. Association between insulin-like growth factor binding protein-3 promoter polymorphism of -1590 C>A and lung cancer susceptibility in a Chinese Han population. Genet Test Mol Biomarkers 2011, 15, 301-6.
24. Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Mutlu F, Alatas F. The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers 2009, 13, 671-8.
25. Zou JH, An L, Chen S, Ren LQ. XPA A23G polymorphism and lung cancer risk: a meta-analysis. Mol Biol Rep 2012, 39, 1435-40.
26. Xu W, Zhou Y, Hang X, Shen D. Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep 2012, 39, 2821-9.
27. Peng WJ, He Q, Yang JX, et al. Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk. Mol Biol Rep 2012, 39, 5187-94.
28. Feng Z, Ni Y, Dong W, Shen H, Du J. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis. Mol Biol Rep 2012, 39, 57-69.
29. Duan WX, Hua RX, Yi W, et al. The association between OGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis of 27 studies. PLoS One 2012, 7, e35970.
30. Borah PK, Shankarishan P, Mahanta J. Glutathione S-transferase M1 and T1 gene polymorphisms and risk of hypertension in tea garden workers of North-East India. Genet Test Mol Biomarkers 2011, 15, 771-6.
31. Darazy M, Balbaa M, Mugharbil A, Saeed H, Sidani H, Abdel-Razzak Z. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese. Genet Test Mol Biomarkers 2011, 15, 423-9.
32. Yadav DS, Devi TR, Ihsan R, et al. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. Genet Test Mol Biomarkers 2010, 14, 715-23.
33. Zintzaras E. Glutathione S-transferaseM1 and T1 genes and susceptibility to chronic myeloid leukemia: a meta-analysis. Genet Test Mol Biomarkers 2009, 13, 791-7.
34. Ada AO, Kunak SC, Hancer F, et al. Association between GSTM1, GSTT1, and GSTP1 polymorphisms and lung cancer risk in a Turkish population. Mol Biol Rep 2012, 39, 5985-93.